Demographic changes in Medicare hip arthoplasty patients

In this observational cohort of medicare beneficiaries undergoing hip arthroplasty, from 1991 to 2008, the average age increased from 74 to 75, mean co-morbid illnesses increased from 1 to 2, and LOS dramatically dropped from 9.1 to 3.7 days, while 30 day mortality decreased from 0.7% to 0.4% (although 30 day readmission increased from 6% to 8.5%). The percentage of those discharged to home also substantially decreased (from 68% to 48%). Hip arthoplasty patients are older, sicker, stay longer, are less likely to go home, and are more likely to be readmitted. These statistics alone make a very strong argument for surgical-co-management (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment